Advancing Cancer Diagnostics, Improving Lives
From translational research to patient treatment, we envision a world where comprehensive insights enrich cancer diagnosis and offer reassurance to all patients.
News & Events
Leica Biosystems Strengthens Portfolio with FDA Clearance of Class II Mismatch Repair (MMR) Panel
The BOND MMR Antibody Panel is now available for clinical use on BOND-III and BOND-MAX Immunohistochemistry (IHC) automated instruments.
Paige and Leica Biosystems Announce Expanded Partnership to Enhance Use of Image Management and Artificial Intelligence Technology in Global Digital Pathology Workflows
Leica Biosystems to adopt Paige's image management and AI system for sale with Leica Biosystems Aperio digital pathology slide scanners
Celebrating Leica Biosystems 150th Anniversary
The history of Leica Biosystems is a history of science and technology innovation.
Leica Biosystems at a Glance
150+ Years of Innovation
2012 - Present
New Era of Science & Technology
2005 - 2011
Global Expansion Accelerates
1989 - 2004
Structuring for Comprehensive Workflow
1930 - 1988
Novel Products Drive Company Growth
1900 - 1930
Microtomy Technology Advances Amidst Wartime Realities
1872 - 1899
The Creation of the Microtome and the Early Years of R. Jung GMBH
Leica Biosystems is proud to be part of Danaher. Danaher’s science and technology leadership puts Leica Biosystems’ solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.